Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Comparative Study Between Conventional Crystalloid Cardioplegic Solution With Modified Del Nido Cardioplegia in Mitral Valve Regurgitation Surgery

ID
Name
Moustafa Omara
Description
Mitral valvuloplasty for correction of chronic mitral regurgitation carries a lower operative mortality and morbidity and improved long-term survival than does mitral valve replacement. Unfortunately, mitral valvuloplasty is not possible in all patients with chronic mitral regurgitation because of unfavorable pathology or lack of experience with this technique
Trial arms
Trial start
2022-07-01
Estimated PCD
2023-03-01
Trial end
2023-03-15
Status
Completed
Treatment
Crystalloid Cardioplegic solution
To compare between conventional crystalloid cardioplegia with modified del Nido cardioplegia in mitral valve regurge replacement surgery.
Arms:
crystalloid cardioplegia with modified del Nido cardioplegia
Other names:
Modified Del Nido Cardioplegia
Size
80
Primary endpoint
myocardial protection
from baseline to 24 hours after the operation
Eligibility criteria
Inclusion Criteria: - Patients scheduled for elective Mitral regurge replacement Surgery with normal Coronaries Exclusion Criteria: 1. Patients with chronic renal disease (previous medical diagnosis or serum creatinine greater than 1.5mg/dL) 2. Left ventricular ejection fraction less than 50%. 3. Previous cardiac surgery 4. Patient with BMI \> 30 5. Severe psychiatric illness 6. Inability or unwillingness to give informed consent for participation
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 80, 'type': 'ACTUAL'}}
Updated at
2023-05-06

1 organization

1 product

1 indication

Organization
Mohamed
Product
Crystalloid Cardioplegic
Indication
Mitral Valve Surgery